Secondary outcomes
dysuria, pain
SECONDARY
The evaluation of excellent clinical response obtained at 12 h, 36 h, 48 h, and 72 h showed that the test drug was superior in pain, burning, and burning on urination from 36 to 48 h (Table Evaluation of excellent clinical response at 12 h, 26 h, 48 h, and 72 hEvaluating the time to reach the absence of symptoms according to patients’ reports, 52.41% of group 1 achieved complete resolution of pain within 72 h, and 47.59% were censored, versus 49.28% of group 2 without pain and 50.71% censored. The mean time for complete resolution of pain was 59.42 h (95% CI 56.32 h, 62.52 h) in group 1 and 64.63 h (95% CI 62.52 h, 66.74 h) in group 2, log-rank In the evaluation of sustained healing, 54.93% of group 1 had no pain after 72 h, versus 45.77% of group 2, According to the investigator's opinion, 61.3% of group 1 and 65.0% of group 2 were categorized as very much to much improved, Investigator's evaluation of dysuria according to the Clinical Global Impression scaleThe results with the PP population are also similar for secondary outcomes (data not shown).Seventy-nine percent of participants in group 1 and 87.8% of group 2 had negative urine culture at V1. At V2, 93.3% of participants in group 1 and 94.8% in group 2 had negative results; 13% of group 1 and 31.3% of group 2 with 